Literature DB >> 22279124

Infection with Cryptosporidium hominis provides incomplete protection of the host against Cryptosporidium parvum.

Abhineet Sheoran1, Anthony Wiffin, Giovanni Widmer, Pradeep Singh, Saul Tzipori.   

Abstract

Cryptosporidium hominis and Cryptosporidium parvum, which infect humans equally, are genetically/antigenically almost identical. It remains unclear, however, whether infection with C. hominis protects against C. parvum. Gnotobiotic piglets were used to investigate cross-protection. After ≥3 days of recovery from C. hominis infection, the piglets were completely protected against subsequent challenge with C. hominis but only partially against challenge with C. parvum, as compared with age-matched control animals challenged with either species. In conclusion, C. hominis-specific immunity was sufficient to completely protect against challenge with the same species but insufficient to provide the same level of protection against C. parvum.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22279124      PMCID: PMC3415952          DOI: 10.1093/infdis/jir874

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

Review 1.  The biology of Cryptosporidium.

Authors:  S Tzipori; G Widmer
Journal:  Contrib Microbiol       Date:  2000

2.  Divalent Cp15-23 vaccine enhances immune responses and protection against Cryptosporidium parvum infection.

Authors:  K Liu; D Zai; D Zhang; Q Wei; G Han; H Gao; B Huang
Journal:  Parasite Immunol       Date:  2010-05       Impact factor: 2.280

3.  Infectivity of a Cryptosporidium parvum isolate of cervine origin for healthy adults and interferon-gamma knockout mice.

Authors:  Pablo C Okhuysen; Stephen M Rich; Cynthia L Chappell; Kevin A Grimes; Giovanni Widmer; Xiaochuan Feng; Saul Tzipori
Journal:  J Infect Dis       Date:  2002-04-16       Impact factor: 5.226

4.  Differential evolution of repetitive sequences in Cryptosporidium parvum and Cryptosporidium hominis.

Authors:  Sultan Tanriverdi; Giovanni Widmer
Journal:  Infect Genet Evol       Date:  2005-03-17       Impact factor: 3.342

5.  Major antigens of Cryptosporidium parvum recognised by serum antibodies from different infected animal species and man.

Authors:  J M Répérant; M Naciri; S Iochmann; M Tilley; D T Bout
Journal:  Vet Parasitol       Date:  1994-10       Impact factor: 2.738

6.  Susceptibility and serologic response of healthy adults to reinfection with Cryptosporidium parvum.

Authors:  P C Okhuysen; C L Chappell; C R Sterling; W Jakubowski; H L DuPont
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

7.  Cryptosporidium parvum: the contribution of Th1-inducing pathways to the resolution of infection in mice.

Authors:  Humphrey N Ehigiator; Nina McNair; Jan R Mead
Journal:  Exp Parasitol       Date:  2006-08-22       Impact factor: 2.011

8.  The genome of Cryptosporidium hominis.

Authors:  Ping Xu; Giovanni Widmer; Yingping Wang; Luiz S Ozaki; Joao M Alves; Myrna G Serrano; Daniela Puiu; Patricio Manque; Donna Akiyoshi; Aaron J Mackey; William R Pearson; Paul H Dear; Alan T Bankier; Darrell L Peterson; Mitchell S Abrahamsen; Vivek Kapur; Saul Tzipori; Gregory A Buck
Journal:  Nature       Date:  2004-10-28       Impact factor: 49.962

9.  The antibody response to 27-, 17-, and 15-kDa Cryptosporidium antigens following experimental infection in humans.

Authors:  D M Moss; C L Chappell; P C Okhuysen; H L DuPont; M J Arrowood; A W Hightower; P J Lammie
Journal:  J Infect Dis       Date:  1998-09       Impact factor: 5.226

10.  Antigenic differences within the Cryptosporidium hominis and Cryptosporidium parvum surface proteins P23 and GP900 defined by monoclonal antibody reactivity.

Authors:  Gregory D Sturbaum; Deborah A Schaefer; B Helen Jost; Charles R Sterling; Michael W Riggs
Journal:  Mol Biochem Parasitol       Date:  2008-03-04       Impact factor: 1.759

View more
  16 in total

1.  Systemic and Mucosal Immune Responses to Cryptosporidium-Vaccine Development.

Authors:  Jacob G Ludington; Honorine D Ward
Journal:  Curr Trop Med Rep       Date:  2015-09-01

2.  Prevalence and risk factors of Cryptosporidium infection in farmed pigs in Zhejiang, Guangdong, and Yunnan provinces, China.

Authors:  Yang Zou; Jian-Gang Ma; Dong-Mei Yue; Wen-Bin Zheng; Xiao-Xuan Zhang; Quan Zhao; Xing-Quan Zhu
Journal:  Trop Anim Health Prod       Date:  2017-02-06       Impact factor: 1.559

Review 3.  A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium.

Authors:  William Checkley; A Clinton White; Devan Jaganath; Michael J Arrowood; Rachel M Chalmers; Xian-Ming Chen; Ronald Fayer; Jeffrey K Griffiths; Richard L Guerrant; Lizbeth Hedstrom; Christopher D Huston; Karen L Kotloff; Gagandeep Kang; Jan R Mead; Mark Miller; William A Petri; Jeffrey W Priest; David S Roos; Boris Striepen; R C Andrew Thompson; Honorine D Ward; Wesley A Van Voorhis; Lihua Xiao; Guan Zhu; Eric R Houpt
Journal:  Lancet Infect Dis       Date:  2014-09-29       Impact factor: 25.071

Review 4.  Controlled Human Infection Models To Accelerate Vaccine Development.

Authors:  Robert K M Choy; A Louis Bourgeois; Christian F Ockenhouse; Richard I Walker; Rebecca L Sheets; Jorge Flores
Journal:  Clin Microbiol Rev       Date:  2022-07-06       Impact factor: 50.129

Review 5.  The Stem Cell Revolution Revealing Protozoan Parasites' Secrets and Paving the Way towards Vaccine Development.

Authors:  Alena Pance
Journal:  Vaccines (Basel)       Date:  2021-01-31

6.  A pig model of the human gastrointestinal tract.

Authors:  Quanshun Zhang; Giovanni Widmer; Saul Tzipori
Journal:  Gut Microbes       Date:  2013-04-02

Review 7.  Prospects for immunotherapy and vaccines against Cryptosporidium.

Authors:  Jan R Mead
Journal:  Hum Vaccin Immunother       Date:  2014-03-17       Impact factor: 3.452

8.  Cryptosporidium suis infection in post-weaned and adult pigs in Shaanxi province, northwestern China.

Authors:  Qing Lin; Xing-Ye Wang; Jian-Wen Chen; Ling Ding; Guang-Hui Zhao
Journal:  Korean J Parasitol       Date:  2015-02-27       Impact factor: 1.341

9.  Genetic modification of the diarrhoeal pathogen Cryptosporidium parvum.

Authors:  Sumiti Vinayak; Mattie C Pawlowic; Adam Sateriale; Carrie F Brooks; Caleb J Studstill; Yael Bar-Peled; Michael J Cipriano; Boris Striepen
Journal:  Nature       Date:  2015-07-15       Impact factor: 49.962

10.  The Burden of Cryptosporidium Diarrheal Disease among Children < 24 Months of Age in Moderate/High Mortality Regions of Sub-Saharan Africa and South Asia, Utilizing Data from the Global Enteric Multicenter Study (GEMS).

Authors:  Samba O Sow; Khitam Muhsen; Dilruba Nasrin; William C Blackwelder; Yukun Wu; Tamer H Farag; Sandra Panchalingam; Dipika Sur; Anita K M Zaidi; Abu S G Faruque; Debasish Saha; Richard Adegbola; Pedro L Alonso; Robert F Breiman; Quique Bassat; Boubou Tamboura; Doh Sanogo; Uma Onwuchekwa; Byomkesh Manna; Thandavarayan Ramamurthy; Suman Kanungo; Shahnawaz Ahmed; Shahida Qureshi; Farheen Quadri; Anowar Hossain; Sumon K Das; Martin Antonio; M Jahangir Hossain; Inacio Mandomando; Tacilta Nhampossa; Sozinho Acácio; Richard Omore; Joseph O Oundo; John B Ochieng; Eric D Mintz; Ciara E O'Reilly; Lynette Y Berkeley; Sofie Livio; Sharon M Tennant; Halvor Sommerfelt; James P Nataro; Tomer Ziv-Baran; Roy M Robins-Browne; Vladimir Mishcherkin; Jixian Zhang; Jie Liu; Eric R Houpt; Karen L Kotloff; Myron M Levine
Journal:  PLoS Negl Trop Dis       Date:  2016-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.